Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Mechanisms of Mitochondrial Dysfunction in ALS
Disease Discoveries

Mechanisms of Mitochondrial Dysfunction in ALS

By Anna WilliamsNov 7, 2018
Share
Facebook Twitter Email
Jane Wu, MD, PhD, the Dr. Charles L. Mix Research Professor of Neurology and Psychiatry, was a senior author of the new study.

Northwestern Medicine scientists have demonstrated that damage to mitochondria plays a critical early role in a group of neurogenerative diseases, including forms of amyotrophic lateral sclerosis (ALS) and dementia.

“Our study suggests that blocking or reversing mitochondrial damage may provide a therapeutic approach to these devastating diseases,” said Jane Wu, MD, PhD, the Dr. Charles L. Mix Research Professor of Neurology and Psychiatry, and co-corresponding author of the study published in Proceedings of the National Academy of Sciences.

The current findings point to a critical role for mitochondrial damage in FUS proteinopathy, a group of neurogenerative diseases characterized by accumulations of the protein FUS, which include some inherited forms of ALS and frontotemporal dementia.

Previously, research led by Wu and others had suggested that mitochondrial dysfunction may be an important aspect of FUS proteinopathy. However, the molecular mechanisms by which FUS damages mitochondria had remained unclear.

In the current study, investigators demonstrated in cellular and animal models that mitochondrial damage is the earliest detectable defect of FUS proteinopathy — with similar damage also detected in patient samples.

Furthermore, the scientists provided new insights into the particular mechanisms behind the disease: FUS, a nuclear protein, can move into mitochondria, where it disrupts normal function of ATP5B — the catalytic subunit of the key mitochondrial enzyme ATP — and activates the mitochondrial unfolded protein response (UPRmt).

“These findings uncover a previously unknown mechanism of modulating mitochondrial ATP synthesis and advance our understanding of mechanisms underlying FUS proteinopathy,” said Wu, a professor of Neurology in the Division of Neuromuscular Disease.

The study also has potential therapeutic implications: In their experiments, the team demonstrated that down-regulating expression of ATP5B or UPRmt genes improves neurodegenerative phenotypes in a fly model.

Mitochondrial impairment could also potentially serve as a diagnostic biomarker for FUS-associated neurodegenerative diseases, Wu notes.

In future research, the Wu laboratory aims to investigate mechanisms by which FUS accumulates in mitochondria and induces the mitochondrial unfolded protein response. They also aim to identify modifier genes for FUS proteinopathy and new approaches to blocking or reversing FUS-induced neural damage.

Other Northwestern co-authors of the paper include Kazuo Fushimi, PhD, research assistant professor of Neurology in the Division of Neuromuscular Disease; Haipeng Cheng, PhD, a postdoctoral fellow; and Xiaoping Chen, a research associate in the Wu lab.

Wu is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

The study, a collaboration between Northwestern and the Chinese Academy of Sciences in Beijing, was supported by National Institutes of Health grants to Wu, and grants from the National Natural Science Foundation of China and the China Postdoctoral Science Foundation to Li Zhu and Jianwen Deng, respectively.

Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Comments are closed.

Latest News

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.